Literature DB >> 11290430

Chronic myeloid leukaemia. STI 571 magnifies the therapeutic dilemma.

T I Mughal1, J M Goldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11290430     DOI： 10.1016/s0959-8049(00)00454-8

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  3 in total

1.  Chronic myeloid leukemia 2011: successes, challenges, and strategies--proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop.

Authors:  Tariq I Mughal; Jerald P Radich; Richard A Van Etten; Alfonso Quintás-Cardama; Tomasz Skorski; Farhad Ravandi; Daniel J DeAngelo; Carlo Gambacorti-Passerini; Giovanni Martinelli; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2011-09       Impact factor: 10.047

2.  Salvage chemotherapy with donor lymphocyte infusion and STI 571 in a patient relapsing with B-lymphoblastic phase chronic myeloid leukemia after allogeneic bone marrow transplantation.

Authors:  László Gopcsa; Anikó Barta; Anikó Bányai; János Dolgos; Gabriella Halm; Katalin Pálóczi
Journal:  Pathol Oncol Res       Date:  2003-07-14       Impact factor: 3.201

3.  An uneventful pregnancy and delivery, in a case with chronic myeloid leukemia on imatinib.

Authors:  Jovita Martin; Anita Ramesh; Lalitha Devadasan; Jude J Martin
Journal:  Indian J Med Paediatr Oncol       Date:  2011-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.